Actively Recruiting
Homburg Renal Evaluation Study on the Clinical Utility of Early AKI Diagnosis
Led by Universität des Saarlandes · Updated on 2023-12-22
1000
Participants Needed
1
Research Sites
182 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Critically ill patients are at risk of developing a sudden decrease of kidney function which may be detected by a decrease in urine output or is diagnosed on the basis of blood tests for substances normally eliminated by the kidney, primarily creatinine. Because it takes about 24 hours for the creatinine level to rise, even if both kidneys have ceased to function, better markers are needed. This trial is investigating if the marker urinary dickkopf-3 (uDKK3) allows an early prediction of a sudden decrease of kidney function.
CONDITIONS
Official Title
Homburg Renal Evaluation Study on the Clinical Utility of Early AKI Diagnosis
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients treated on the intensive care units of Saarland University Hospital.
You will not qualify if you...
- Patients on renal replacement treatment before admission to the intensive care unit.
- Patients with chronic kidney disease stage CKD G3b or below.
- Known kidney disease.
- Kidney transplantation.
- Intoxications leading to dialysis treatment.
- Participation in other clinical trials.
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Universitätsklinikum des Saarlandes
Homburg, Saarland, Germany, 66421
Actively Recruiting
Research Team
S
Stefan Neuhaus, MD
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here